Our research
We aim to address clinically and etiologically relevant questions regarding chronic inflammatory diseases, and their treatments, spanning from disease susceptibility, predictors of prognosis, and treatment response. We assess the comparative effectiveness and safety of available and emergent treatment options, society costs of disease and treatment outcomes.
Teams
The research group is divided into teams, each focusing on different diseases and/or questions. The teams are co-operating and share equipment, methods, results etc.
- Team Elizabeth Arkema: Epidemiology of sarcoidosis and systemic lupus erythematosus.
- Team Johan Askling: Inflammatory arthritis team.
- Team Thomas Frisell: Multiple sclerosis.
- Team Marie Holmqvist: Rheumatic systemic diseases.
- Team Björn Pasternak: Pharmaco-epidemiology.